Back to results
US 11,261,208 B2Granted
Compounds for use as iron(III) MRI contrast agents
AssigneeThe Research Foundation for The State University of New York
InventorsJanet R. Morrow, Eric M. Snyder, Didar Asik
Life of this patent
Estimating the term…
Abstract
Provided are macrocyclic compounds and compounds with two or more macrocyclic groups, iron coordinated macrocyclic compounds, and iron coordinated compounds with two or more macrocyclic groups. The iron is high-spin iron(III). The iron coordinated compounds may exhibit a negative redox potential (e.g., relative to a normal hydrogen electrode at a biologically relevant pH, for example, a pH of 6.5-7.5). The compounds can be used as MRI contrast agents.
Claims17
A macrocyclic complex comprising:
- a macrocyclic core, wherein the macrocyclic core is a TACN group, an S-substituted TACN, an O-substituted TACN, or a cyclam group having the following structure:
- and Z1, Z2, Z3, and Z4 are each independently H or one or more of the following pendant groups:
- or a deprotonated analog thereof or a stereoisomer thereof, wherein R is methyl, R1, R2, and R3 are each independently a substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted alkyl group, and R1, R2, and R3 are not pendant donors;
- Q1 and Q2 are each independently H, OCH3, CO2H, or CH2CO2G4, G4 is H, C1 to C12 substituted or unsubstituted alkyl groups of linear or branched structure or a (—CH2CH2O—)n group, wherein n is 1-2, Q3 is H, C1 to C12 substituted or unsubstituted alkyl groups of linear or branched structure or a (—CH2CH2O—)n group, wherein n is 1-12, Q4 and Q5 are each independently H, OCH3, CO2H, or substituted or unsubstituted alkyl groups of linear or branched structures, A is a substituted or unsubstituted alkyl group of linear or branched structure with C1 to C12 or is a substituted or unsubstituted aryl group or an amino acid, and
- a high-spin Fe(III) cation complexed to the macrocyclic core and at least one pendant group, or a salt, a partial salt, a hydrate, a polymorph, or a stereoisomer thereof,
- wherein the macrocyclic complex exhibits a redox potential of less than 0 vs. normal hydrogen electrode (NHE) in an aqueous medium at a pH of 6.5-7.5,
- wherein the macrocyclic core has structure I, Z1 is H and Z2 and Z3 are each independently a pendant group;
- wherein the macrocyclic core has structure II, III, or XV, Z1 and Z2 are each independently a pendant group;
- wherein the macrocyclic core has structure XVI, Z1 is a pendant group;
- wherein the macrocyclic core has structure XII, Z4 is a pendant group and Z1, Z2 and Z3 are each independently H or a pendant group, provided that at most two of Z1, Z2, and Z3 are H;
- wherein the macrocyclic core has structure XIII, Z1 and Z3 are each independently a pendant group and Z2 is H or a pendant group;
- wherein for all structures I, II, III, XII, XIII, XIV, XV, and XVI, each of Z1, Z2, Z3 and Z4, as applicable, are selected independently of each other.
9 more elements
Dependencies are inferred from the claim text.